Barrow, Hanley, Mewhinney & Strauss’s Adtran ADTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.82K Buy
+131
New +$2.04K ﹤0.01% 359
2018
Q1
– Sell
-250,946
Closed -$4.86M – 425
2017
Q4
$4.86M Sell
250,946
-18,212
-7% -$404K 0.01% 208
2017
Q3
$6.46M Sell
269,158
-1,185
-0.4% -$26.2K 0.01% 184
2017
Q2
$5.58M Hold
270,343
– – 0.01% 195
2017
Q1
$5.61M Buy
270,343
+8,906
+3% +$193K 0.01% 194
2016
Q4
$5.84M Sell
261,437
-900
-0.3% -$18.2K 0.01% 189
2016
Q3
$5.02M Buy
262,337
+10,414
+4% +$192K 0.01% 189
2016
Q2
$4.7M Sell
251,923
-888
-0.4% -$16.9K 0.01% 196
2016
Q1
$5.11M Buy
252,811
+13,932
+6% +$258K 0.01% 172
2015
Q4
$4.11M Buy
238,879
+10,833
+5% +$172K 0.01% 169
2015
Q3
$3.33M Buy
228,046
+17,255
+8% +$272K 0.01% 189
2015
Q2
$3.42M Buy
+210,791
New +$3.62M ﹤0.01% 200

Other funds holding ADTN

Barrow, Hanley, Mewhinney & Strauss's ADTN Position: Q2 2026 in Review

Barrow, Hanley, Mewhinney & Strauss opened a new position in Adtran (ADTN) in Q2 2026: 131 shares worth $1.82K. The stake represents ﹤0.01% of the portfolio and ranks #359 among its holdings. This is a return to the name: Barrow, Hanley, Mewhinney & Strauss previously reported a position in ADTN as recently as Q4 2017.

Barrow, Hanley, Mewhinney & Strauss first reported a position in ADTN in Q2 2015 and has held it in 12 quarters since. The position peaked at $6.46M in Q3 2017. 250 funds tracked by Wall St. Rank hold ADTN as of Q2 2026.

  • Barrow, Hanley, Mewhinney & Strauss held 131 shares of Adtran worth $1.82K as of Q2 2026.
  • Adtran was a new Barrow, Hanley, Mewhinney & Strauss position in Q2 2026.
  • Adtran made up ﹤0.01% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q2 2026, its #359 holding.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Adtran in Q2 2015 and has held it in 12 quarters since.
  • Barrow, Hanley, Mewhinney & Strauss's Adtran position peaked at $6.46M in Q3 2017.
  • 250 funds tracked by Wall St. Rank held Adtran as of Q2 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2026, filed 12 Aug 2026.